Good morning, everyone, and how are you today? A warm and shiny sun is enveloping the Pharmalot campus, where the shortest of short people has left for the local schoolhouse and the official mascots are happily snoozing away. As for us, yes, we are engaging in our familiar ritual – downing cups of stimulation. Our flavor today is Malt Shoppe Mocha. Like a curious drug developer, we also like to experiment. While you consider doing the same, here are some tidbits to get you going. Have a smashing day…
Despite criticism over tax inversions, Mylan ceo Heather Bresch says the tactic is needed for growth; New study results confirm Ebola can linger in semen for many months after patients recover from its life-threatening symptoms; Theranos claims to use its own technology to quickly process many different lab tests from “a few drops of blood,” but the company is mostly using machines provided by Siemens; and in case you missed it, Jeb Bush released his health care plan this week and among the proposals are two items that dovetail with pharmaceutical industry sentiment.